NEW Blood-Sharing DRUG Rampant—HIV Spikes!

Person sleeping on a bench in a public area.

A single syringe, passed from hand to hand, is fueling an HIV wildfire among Fiji’s youth—and the perilous logic behind “bluetoothing” may soon ignite outbreaks wherever desperation and addiction collide.

Story Snapshot

The bluetoothing drug trend has led to an elevenfold surge in HIV cases in Fiji, threatening to overwhelm the nation’s healthcare system.
Economic hardship and methamphetamine addiction drive youth, some as young as 13, to share drug-laced blood via syringes.
This risky practice originated in South Africa and is spreading as a cost-saving measure among vulnerable populations.
Nearly half of those diagnosed with HIV in Fiji avoid treatment, multiplying the risk of transmission and compounding the crisis.

Bluetoothing: Where Addiction and Economics Collide

Teenagers in Fiji gather in dimly lit rooms, passing a syringe containing not just methamphetamine, but the very blood of a peer. This is bluetoothing—a cost-cutting, high-risk ritual that has transformed from a whispered secret to a public health emergency. Methamphetamine-filled syringes cost about 10 Fijian dollars, but splitting a fix through blood-sharing means everyone gets high for less. The trade-off? Direct exposure to HIV and other bloodborne killers, with cases rising elevenfold in a decade. The economics are brutal, but the consequences even more so.

Fiji scrambles to contain HIV outbreak driven by meth use and 'bluetoothing' https://t.co/w71Y3uBCRO via @ABCaustralia

— pah-tea (@leatualoa) March 14, 2025

Bluetoothing’s spread among teenagers and young adults marks a new chapter in the global HIV story. In Fiji, children as young as 13 now test positive for HIV due to intravenous drug use, shattering the illusion that the epidemic only affects marginalized adults. Peer pressure and misinformation drive the practice: users believe sharing blood amplifies the high, while the reality is a chemical cocktail mixed with infectious disease. The social cost is steep—families unravel, youth futures dim, and communities grapple with a syndemic blending addiction, HIV, and hepatitis outbreaks.

From South Africa’s Streets to Fiji’s Crisis: How Bluetoothing Emerged

Bluetoothing didn’t originate in Fiji. Its roots trace to South Africa, where users of “nyaope,” a potent drug blend often laced with HIV medications, began injecting and exchanging blood to stretch their supply. The practice migrated across oceans, finding fertile ground wherever poverty, addiction, and limited healthcare intersect. In South Africa, the drug’s ingredients—sometimes including efavirenz, an antiretroviral—create a dangerous cycle where HIV treatments become part of the addiction. The mechanism is the same everywhere: inject, withdraw, share, repeat. Each link in the chain is a potential vector for HIV, hepatitis B, and hepatitis C.

The global backdrop amplifies Fiji’s crisis. Meta-analyses show that 18% of people who inject drugs worldwide already live with HIV, and over half carry hepatitis C. Bluetoothing accelerates this risk exponentially, as the direct blood-to-blood contact is even more hazardous than traditional needle-sharing. Economic constraints, misinformation, and normalized group behavior fuel the fire, especially in regions where harm reduction resources are scarce and stigma keeps users in the shadows.

Public Health on the Brink: The Human and Systemic Toll

Fiji’s health system is straining under the weight of a dual epidemic: methamphetamine addiction and infectious disease. Hospitals see a flood of cases not just for HIV, but for hepatitis B, hepatitis C, and the cascade of organ damage and sepsis bluetoothing brings. Nearly half of those diagnosed with HIV in Fiji avoid further treatment, often due to stigma, fear, or lack of resources. This untreated reservoir increases the likelihood that every shared syringe is also a vessel for a high viral load—amplifying transmission rates and complicating containment.

The fallout extends beyond physical health. Youth diagnosed with HIV and battling addiction face psychological trauma: depression, anxiety, memory loss, and suicidal thoughts. Stigma and discrimination compound the crisis, isolating individuals and deterring them from seeking help. Families fracture under the strain, and communities lose the next generation to illness and addiction. Economic productivity declines as more young people become chronically ill, and criminality rises in the wake of desperation and untreated substance abuse.

What Experts Say: Solutions, Stigma, and the Path Forward

Researchers like Dr. Apisalome Movono of Massey University warn that methamphetamine’s immune-suppressing effects make HIV progression even more aggressive. Medical Services Pacific urges a shift from punishment to compassion, arguing that addiction is a medical condition, not a moral failing. Public health messaging now centers on breaking the stigma and encouraging treatment, but with nearly half avoiding care, the challenge looms large. Experts agree: addressing bluetoothing demands a multifaceted response—combining education, addiction treatment, infectious disease management, and community support.

The broader lesson is sobering. Bluetoothing’s emergence in Fiji, after first appearing in South Africa, raises alarms for any region where economic hardship, drug availability, and healthcare gaps converge. The global drug trade and migration mean these practices can appear anywhere, anytime. Prevention requires vigilance, resources, and an honest reckoning with the social and economic conditions that fuel desperate choices. The open question remains: will the world act before the next outbreak, or only after another generation is lost?